了解客户和提供商在尼日利亚实施皮下储存美德酸 (DMPA-SC) 以进行自我注射计划的观点
Sneha Challa1, Madeline Griffith2, Ayobambo Jegede3
1Institute for Health & Aging, University of California, San Francisco, San Francisco, California, USA sneha.challa@ucsf.edu.
BMJ global health
|February 26, 2026
概括
皮下储存麦德洛西孕酸 (DMPA-SC) 自注射 (SI) 计划从客户接受的同行支持和提供者忠诚度的培训辅助中受益. 积极的后续行动和共享决策提高了计划的可行性和以客户为中心.
科学领域:
- 生殖健康 生殖健康
- 实施科学 实施科学
- 公共卫生 公共卫生
背景情况:
- 皮下储存的美德酸 (DMPA-SC) 是一种注射避孕药,已批准自注射 (SI).
- 扩展SI计划的DMPA-SC需要了解实施促进者和障碍.
- 实施科学框架对于评估此类计划至关重要.
研究的目的:
- 探索尼日利亚SI的DMPA-SC的提供商和客户体验.
- 确定影响SI计划DMPA-SC实施结果的因素.
- 为扩大DMPA-SCSI计划提供基于证据的建议.
主要方法:
- 在拉各斯,恩古和高原州 (2021-2023) 进行了N=141个提供商和N=129个客户访谈.
- 使用的 普罗克特等人. "的实施科学框架.
- 按实施结果编码的观察和引用:可接受性,适当性,可行性,忠实性,成本,效率,安全性,以客户为中心性和采用性.
主要成果:
- 社交网络学习提高了客户的接受度和DMPA-SC SI的采用.
- 提供商需要支持外展成本和可行性;一些提供商通过非基于能力的SI决策限制了以客户为中心.
- 复习培训可以提高供应商对SI协议的忠诚度;客户希望主动的后续支持.
结论:
- 利用对DMPA-SC SI可接受性的同行支持和对忠诚度和采用性的培训辅助.
- 强调以客户为中心的共享决策,并投资于可行性后续支持.
- 计划扩展应优先考虑这些策略,以改善DMPA-SC SI服务的提供和采用.
相关概念视频
Intrauterine Drug Delivery Systems
58
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
58
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
62
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
62
Drug Delivery: Parenteral Route
1.9K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.9K
Insulin Formulations: Types and Delivery
872
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
872
Transdermal Drug Delivery Systems
57
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
57
Modified-Release Drug Delivery Systems: Rate-Programmed I
53
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
53


